Total Funding
46
17
Total FundingGrant raised
Growth Score
-1 pts
Heat Score
12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
397184
Recon Therapeutics has developed a new drug delivery technology that simplifies reconstitution of a lyophilized drug with solvent at the POC
- Hojun Suk: Co-FounderPast Role: Seoul Semiconductor, Development Center Researcher
About the Company
Recon Therapeutics has developed The LyoKit Disposable Reconstitution System, a new patent-pending drug delivery technology that simplifies patient self-administration of biologic drugs. The LyoKit System is novel because it does not reinvent the syringe; instead, it couples a standard 3mL syringe with an external pressurized water chamber,
resulting in a simple one-step reconstitution process. The device is completely disposable, and is designed to function as its own sharps container, mitigating needle safety concerns.
